Blood coagulation and fibrinolysis in aortic valve stenosis: links with inflammation and calcification

Area of Science:

• Cardiovascular Medicine
• Pathobiology
• Biochemistry

Background:

• Aortic valve stenosis (AS) is a growing concern in aging populations, yet its underlying pathology remains unclear, and effective treatments are lacking.
• AS progression involves inflammatory and fibroproliferative changes, sharing similarities with atherosclerosis.
• Key coagulation proteins and inhibitors are upregulated in aortic stenotic valves, particularly on cells near calcified regions.

Purpose of the Study:

• To review the current understanding of blood coagulation and fibrinolysis in aortic valve stenosis.
• To highlight the interplay between coagulation, inflammation, and calcification in AS pathogenesis.

Main Methods:

• Literature review of studies investigating coagulation and fibrinolysis in aortic valve stenosis.
• Analysis of data on the expression of coagulation factors and inhibitors in stenotic aortic valves.
• Examination of the relationship between coagulation, inflammation, and valvular calcification.

Main Results:

• Increased expression of coagulation factors (tissue factor, prothrombin, factor XIII, von Willebrand factor) and inhibitors (tissue factor pathway inhibitor, plasminogen activator inhibitor-1) in AS.
• Elevated plasminogen activator inhibitor-1 levels correlate with AS severity.
• Significant cross-talk exists between inflammation and coagulation within stenotic valve tissue, promoting calcification.

Conclusions:

• Coagulation and fibrinolysis pathways are significantly implicated in the pathobiology of aortic valve stenosis.
• The interaction between inflammation and coagulation is a key driver of valvular calcification in AS.
• Further research into these mechanisms could pave the way for novel therapeutic strategies.